Cyber Monday saleUp to 70% OFF
Recordati Industria Chimica e Farmaceutica S.p.A.Recordati Industria Chimica e Farmaceutica S.p.A.Recordati Industria Chimica e Farmaceutica S.p.A.

Recordati Industria Chimica e Farmaceutica S.p.A.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

RCDTF chart


Full chart

RCDTF upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.09 B‬ USD
Dividend yield (indicated)
2.38%
Price to earnings Ratio (TTM)
24.48
Basic EPS (TTM)
2.29 USD
Net income (FY)
‪429.59 M‬ USD
Revenue (FY)
‪2.30 B‬ USD
Shares float
‪96.54 M‬
Beta (1Y)
0.59

Employees


Employees (FY)
‪4.46 K‬
Change (1Y)
+86 +1.97%
Revenue / Employee (1Y)
‪515.90 K‬ USD
Net income / Employee (1Y)
‪96.43 K‬ USD

About RECORDATI ORD


Sector
Health Technology
CEO
Robert Koremans
Headquarters
Milan
Website
recordati.it
Founded
1996
ISIN
IT0003828271
FIGI
BBG000BW0YV7
Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. It operates through the Specialty and Primary Care, and Rare Diseases segments. The Specialty and Primary Care segment includes pharmaceutical chemical operations. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

RCDTF news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RCDTF is 52.25 USD — it has increased by 1.26% in the past 24 hours. Watch Recordati Industria Chimica e Farmaceutica S.p.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Recordati Industria Chimica e Farmaceutica S.p.A. stocks are traded under the ticker RCDTF.
We've gathered analysts' opinions on Recordati Industria Chimica e Farmaceutica S.p.A. future price: according to them, RCDTF price has a max estimate of 68.23 USD and a min estimate of 50.38 USD. Watch RCDTF chart and read a more detailed Recordati Industria Chimica e Farmaceutica S.p.A. stock forecast: see what analysts think of Recordati Industria Chimica e Farmaceutica S.p.A. and suggest that you do with its stocks.
RCDTF reached its all-time high on Nov 1, 2021 with the price of 63.96 USD, and its all-time low was 4.98 USD and was reached on Mar 9, 2009. View more price dynamics on RCDTF chart.
See other stocks reaching their highest and lowest prices.
RCDTF stock is 1.24% volatile and has beta coefficient of 0.59. Track Recordati Industria Chimica e Farmaceutica S.p.A. stock price on the chart and check out the list of the most volatile stocks — is Recordati Industria Chimica e Farmaceutica S.p.A. there?
Today Recordati Industria Chimica e Farmaceutica S.p.A. has the market capitalization of ‪11.20 B‬, it has decreased by −3.80% over the last week.
Yes, you can track Recordati Industria Chimica e Farmaceutica S.p.A. financials in yearly and quarterly reports right on TradingView.
Recordati Industria Chimica e Farmaceutica S.p.A. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
Recordati Industria Chimica e Farmaceutica S.p.A. revenue for the last quarter amounts to ‪620.61 M‬ USD, despite the estimated figure of ‪621.73 M‬ USD. In the next quarter, revenue is expected to reach ‪604.94 M‬ USD.
RCDTF net income for the last quarter is ‪125.85 M‬ USD, while the quarter before that showed ‪109.01 M‬ USD of net income which accounts for 15.44% change. Track more Recordati Industria Chimica e Farmaceutica S.p.A. financial stats to get the full picture.
Recordati Industria Chimica e Farmaceutica S.p.A. dividend yield was 2.46% in 2023, and payout ratio reached 63.40%. The year before the numbers were 2.97% and 75.69% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 5, 2024, the company has ‪4.46 K‬ employees. See our rating of the largest employees — is Recordati Industria Chimica e Farmaceutica S.p.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Recordati Industria Chimica e Farmaceutica S.p.A. EBITDA is ‪883.14 M‬ USD, and current EBITDA margin is 34.02%. See more stats in Recordati Industria Chimica e Farmaceutica S.p.A. financial statements.
Like other stocks, RCDTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Recordati Industria Chimica e Farmaceutica S.p.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Recordati Industria Chimica e Farmaceutica S.p.A. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Recordati Industria Chimica e Farmaceutica S.p.A. stock shows the buy signal. See more of Recordati Industria Chimica e Farmaceutica S.p.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.